Predictive Value of Heart Rate Variability on Cardiorespiratory Events

NCT04303494 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 292

Last updated 2023-04-03

No results posted yet for this study

Summary

The aim of this study are to investigate whether heart rate variability (HRV) parameters derived from nonlinear time series analysis at five different time points have prognostic utility for assessing the risk of postimmunisation AOP in very preterm/very low birth weight infants immunised in the hospital.

Conditions

  • Post-immunisation Apnoea and Bradycardia of Prematurity (AOP)

Interventions

BIOLOGICAL

immunisation

combined diphtheria, tetanus, acellular pertussis, poliomyelitis, hepatitis B, ± Haemophilus influenzae type B and simultaneous pneumococcus (PCV13) vaccination

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Sven Schulzke, Prof. Dr. med · University Children's Hospital Basel, UKBB

Eligibility

Min Age
3 Days
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2022-11-05
Completion
2022-11-05

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04303494 on ClinicalTrials.gov